UMR 1092 INSERM – University of Limoges – Anti-infective agents: Supports resistance and molecular therapeutic innovations
- Director: Professor Marie-Cécile PLOY – Assistant Director: Professor Sophie ALAIN
Faculté de Médecine
2 rue du Docteur Marcland
87025 LIMOGES CEDEX – France
- Telephone: +33 (0)5 55 43 59 74
- Telecopie: +33 (0)5 55 05 67 22
- Site internet
Unit guidelines concern the molecular mechanisms of resistance to antimicrobials, antibiotics and antivirals. The work focused on the study of the diversity of bacterial strains and virus resistant, to better understand the evolution of acquired resistance within microbial genomes and the kinetics of the emergence of resistance.
Team 1: Role of integrons in multidrug resistance of bacteria to antibiotics
Leader: Professor Marie-Cécile PLOY
Team 2: Study of Cytomegalovirus (CMV) antiviral resistance
Leader: Professor Sophie ALAIN
The team 2 is integrated to the FHU SUPORT strategy. This team is studying the dynamics of the evolution of bacterial genomes due to antibiotic selection pressure. This work will help to better understand the evolution of the acquisition of resistance to antibiotics in bacteria, as well as environmental signals governing the acquisition.
THEMES IN RELATION TO ORGAN TRANSPLANTATION (TEAM 2)
- Translational study on non-response factors to a curative anti-CMV treatment in kidney transplant recipients (ORPHAVIC national PHRC: ancillary study supported by CNR CMV)
- Evaluation of the CMV infection risk in the R+ kidney transplant recipient following the analysis of cellular immunity by the QuantiFERON®-CMV test.
- Study of the cellular diffusion and activation mechanisms of anti-CMV drugs (in collaboration with UMR 850)